4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001140361-23-020316
Chief Legal and HR Officer sold 3,750 shares at $20.00 ($75,000)
- Chief Legal and HR Officer acquired 3,750 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bizily Scott · Chief Legal and HR Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-21 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,750 | $8.04 | $30,150 | 5,859 | D |
| 2023-04-21 | Sale : show line 2 in the form 10b5-1 | −3,750 | $20.00 | $75,000 | 2,109 | D |
| Open-market sales · 3,750 sh · avg $20.00 · $75,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-04-21 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −3,750 | 52,500 | D |
Loading xslF345X04/form4.xml…